GSK vs SYBT · P/E 13, $103.31B cap vs P/E 15, rev $246.0M
GlaxoSmithKline PLC ADR (GSK) versus Stock Yards Bancorp Inc (SYBT) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Stock Yards Bancorp Inc (SYBT) is a banks - regional company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SYBT revenue for 2026-06-30 was $246.0M. Net income was $76.7M. SYBT currently screens at market cap $2.13B and trailing P/E 14.9.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SYBT currently screens at market cap $2.13B and trailing P/E 14.9.
Not investment advice. Open the GSK and SYBT stock pages for the full models.
Not investment advice.